The U.S. Food and Drug Administration has approved a new drug to treat postmenopausal women who experience pain during sex.
The drug Osphena (ospemifene) mimics the effects of estrogen on vaginal tissue, which can become thinner, drier and more fragile from menopause. The pill, taken with food once a day, makes vaginal tissue thicker and less fragile to reduce pain during sex (called dyspareunia).
“Dyspareunia is among the problems most frequently reported by postmenopausal women,” said Dr. Victoria Kusiak. The safety and effectiveness of Osphena was established in three clinical studies involving nearly 1,900 postmenopausal women with signs of vulvar and vaginal atrophy